Newsletter May 2018 No. 185
Top News
The 30th JPMA Policy Seminar was held.
The 30th JPMA Policy Seminar" was held on March 12, 2018 at the Tokyo Conference Center Shinagawa (Minato-ku, Tokyo) under the theme of "The Pharmaceutical Industry at a Turning Point in Healthcare: Promoting the Utilization of Medical Big Data". The seminar was held under the theme of "Promotion of Utilization of Medical Big Data". As a result of the accumulation and accumulation of data for the treatment of individual patients through the advancement of ICT technology, data can now be used for research into disease prevention, preemptive medicine, and other areas. On the other hand, there are still areas that need improvement, such as the generation of data suitable for research and procedures for third-party use of data. In this policy seminar, the current status of utilization of medical big data to create new drugs and treatments, issues in more effective utilization, and organic collaboration between industry, academia, and government were discussed, and many participants listened attentively.
Topics
- JPMA Consumer Consultation Review Committee 2018 "JPMA Consumer Consultation Review Committee Forum.
- Held the "1st Meeting of Code and Compliance Management Managers
- Held "2018 Life Science Intellectual Property Forum
- JPMA Press Tour" was held Tohoku University Tohoku Medical Megabank Organization (TMMO), which is working on the construction of a biobank that combines medical and genomic information with a view to future medical care.
- The 9th Workshop on Environmental Technology was held.
- The 3rd Symposium on Utilization of Medical Information Database held.
Policy Research Institute
Approval Status and Review Period of New Drugs - 2017 Results and Comparison with the Past 10 Years
From JPMA
Further Promotion of Medical Big Data Utilization to Bring New Value to Patients